Journal
THERAPEUTIC DELIVERY
Volume 10, Issue 5, Pages 281-293Publisher
Newlands Press Ltd
DOI: 10.4155/tde-2019-0019
Keywords
chitosan; glibenclamide; quercetin; skin-permeating nanogel
Categories
Funding
- International Medical University (IMU), Malaysia [BPI-01-14(31)2017]
Ask authors/readers for more resources
Aim: Our aim was to develop and characterize a nanogel formulation containing both glibenclamide and quercetin and to explore the permeation profile of this combination. Methods: Drug-loaded nanogel was prepared by ionic gelation. In addition, optimum encapsulation efficiencies of glibenclamide and quercetin were also obtained. The average nanoparticle size at optimum conditions was determined by Zetasizer. Results: The particle size of the nanogel was found to be 370.4 +/- 4.78nm with a polydispersity index of 0.528 +/- 0.04, while the lambda potential was positive in a range of 17.6 to 24.8mV. The percentage cumulative drug release also showed favorable findings. Conclusion: The chitosan nanogel could be a potential alternative for delivering glibenclamide and quercetin through skin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available